Determinants of women's decision making on whether to treat nausea and vomiting of pregnancy pharmacologically

Journal of Midwifery and Women's Health

Volumn 49, Issue 4, 2004, Pages 350-354

  Baggley, Anne ^b   Navioz, Yvette ^b   Maltepe, Caroline ^b   Koren, Gideon ^b   Einarson, Adrienne ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

Decision making; Nausea and vomiting; Pregnancy; Treatment

Indexed keywords

BENDECTIN; DIMENHYDRINATE; DOXYLAMINE; GINGER EXTRACT; PYRIDOXINE;

ADULT; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DECISION MAKING; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG INFORMATION; DRUG SAFETY; FEMALE; FOLLOW UP; GINGER; HUMAN; HYPEREMESIS GRAVIDARUM; INTERVIEW; MAJOR CLINICAL STUDY; MANIPULATIVE MEDICINE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF CONCEPT; TABLET FORMULATION; TELEPHONE; TERATOGENICITY;

ADULT; ANTIEMETICS; ATTITUDE TO HEALTH; DECISION MAKING; DELAYED-ACTION PREPARATIONS; DOXYLAMINE; DRUG COMBINATIONS; FEMALE; HUMANS; NAUSEA; ONTARIO; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PYRIDOXINE; QUESTIONNAIRES; VOMITING; WOMEN'S HEALTH;

EID: 3242752797     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmwh.2004.03.011     Document Type: Article

References (24)

1. Koch K.L. Frissora C.L. Nausea and vomiting during pregnancy Gastroenterol Clin North Am 32 2003 201-234
2. Lacroix R. Eason E. Melzack R. Nausea and vomiting during pregnancy: A prospective study of its frequency, intensity, and patterns of change Am J Obstet Gynecol 182 2000 931-937
3. O'Brien B. Evans M. White-McDonald E. Isolation from "being alive": Coping with severe nausea and vomiting of pregnancy Nurs Res 51 2002 302-308
4. Gadsby R. Barnie-Adshead A.M. Jagger C. A prospective study of nausea and vomiting during pregnancy Br J Gen Pract 43 1993 245-248
5. Mazzotta P. Psychosocial morbidity among women with nausea and vomiting of pregnancy: Prevalence and association with anti-emetic therapy J Psychosom Obstet Gynaecol 21 2000 129-136
6. Attard C.L. Kohli M.A. Coleman S. Bradley C. Hux M. Atanckovic G. et al. The burden of illness of severe nausea and vomiting of pregnancy in the United States Am J Obstet Gynecol 186 2002 S220-S227
7. Mazzotta P. Factors associated with elective termination of pregnancy among Canadian and American women with nausea and vomiting of pregnancy J Psychosom Obstet Gynaecol 22 2001 7-12
8. Eliakim R. Abulafia O. Sherer D.M. Hyperemesis gravidarum: A current review Am J Perinatol 17 2000 207-218
9. Brent R. Medical, social and legal implications of treating nausea and vomiting of pregnancy Am J Obstet Gynecol 186 2002 S262-S266
10. O'Brien A. Naber S. Nausea and vomiting during pregnancy: Effects on the quality of women's lives Birth 19 1992 138-143 138
11. Jewell D. Young G. Interventions for nausea and vomiting in early pregnancy Cochrane Database Syst Rev 4 2003 CD000145
12. Sahakian V. Rouse D. Sipes S. Rose N. Niebyl J. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: A randomized, double-blind placebo-controlled study Obstet Gynecol 78 1991 33-36
13. Fischer-Rasmussen W. Kjaer S.K. Dahl C. Asping U. Ginger treatment of hyperemesis gravidarum Eur J Obstet Gynecol Reprod Biol 38 1991 19-24
14. Vutyavanich T. Kraisarin T. Ruangsri R. Ginger for nausea and vomiting in pregnancy: Randomized, double-masked, placebo-controlled trial Obstet Gynecol 97 2001 577-582
15. Portnoi G. Chng L. Karimi-Tabesh L. Koren G. Tan M. Einarson A. Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy (NVP) Am J Obstet Gynecol 189 2003 1374-1377
16. Einarson T.R. Leeder J.S. Koren G. Method for meta-analysis of epidemiological studies Drug Intell Clin Pharm 22 1988 813-824
17. Ornstein M. Einarson A. Koren G. Bendectin/diclectin for morning sickness: A Canadian follow-up of an American tragedy Reprod Toxicol 9 1995 1-6
18. Diclectin Product Monograph 2003 Duchesnay, Inc. Laval, Quebec, Canada Compendium of Pharmaceuticals and Specialties (CPS)
19. Atanackovic G. Navioz Y. Moretti M. Koren G. The safety of higher than standard dose of doxylamine-pyridoxine for nausea and vomiting of pregnancy J Clin Pharmacol 41 2001 842-845
20. Lee J. Einarson A. Gallo M. Okotore B. Koren G. Longitudinal change in the treatment of nausea and vomiting of pregnancy in Ontario Can J Clin Pharmacol 7 2000 205-208
21. Koren G. Levichek Z. The teratogenicity of drugs for nausea and vomiting of pregnancy: Perceived versus true risk Am J Obstet Gynecol 186 2002 S248-S252
22. Hollyer T. Boon H. Georgousis A. Smith M. Einarson A. The use of CAM by women suffering from nausea and vomiting during pregnancy BMC Comp Altern Med 5 2002
23. SOGC. Clinical practice guidelines for the management of nausea and vomiting of pregnancy 1995 The Society of Obstetricians and Gynecologists of Canada November
24. Bonari L.Einarson A.Jasper J.D.Einarson T.R.Koren G. Determinants of women's decision making, regarding the use of antidepressants during pregnancy 2003 (abstract). The North American Society for Psychosocial Obstetrics and Gynecology 31st Annual Meeting, February 19-22, 2003, Lihue, Hawaii